Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s share price traded up 11.3% during trading on Monday. The stock traded as high as $3.60 and last traded at $3.7390. Approximately 11,364 shares changed hands during trading, a decline of 85% from the average daily volume of 76,952 shares. The stock had previously closed at $3.36.
Analyst Ratings Changes
Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, October 8th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, Anbio Biotechnology currently has an average rating of “Hold”.
View Our Latest Analysis on NNNN
Anbio Biotechnology Price Performance
The stock’s 50-day simple moving average is $5.47 and its 200 day simple moving average is $16.73.
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Recommended Stories
- Five stocks we like better than Anbio Biotechnology
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
